文献速递乳房整形与再造

两阶段胸肌前乳房重建中组织扩张器更换为假体时使用与不使用脱细胞真皮基质的结局:一项回顾性队列研究

Outcomes after tissue expander exchange to implant in two-stage prepectoral breast reconstruction with and without acellular dermal matrix: A retrospective cohort study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-12-12

该回顾性队列研究比较了胸肌前两阶段乳房重建中,组织扩张器更换为假体时使用与不使用脱细胞真皮基质(ADM)的第二阶段结局。ADM组68侧乳房、无ADM组61侧乳房在更换术后随访1年,两组在假体波纹、包膜挛缩、假体取出及再次修手术方面无统计学显著差异,无ADM组在假体波纹相关的身体健康和满意度方面BREAST-Q评分改善。

要点

  • ADM组68侧与无ADM组61侧乳房在组织扩张器更换为假体后随访1年。
  • 假体波纹发生率ADM组24.6% vs 无ADM组12.1%,p=0.08,无统计学显著差异。
  • 无ADM组在假体波纹相关的身体健康和满意度方面BREAST-Q评分改善(p=0.04)。

核心结论

  • 在胸肌前第二阶段假体乳房重建中,使用ADM对假体波纹、包膜挛缩、假体取出、再次修手术需求及患者报告满意度方面无主要获益。

研究设计与样本

  • 回顾性队列研究,纳入连续接受胸肌前组织扩张器乳房重建并使用或不使用ADM的患者,在组织扩张器更换为假体后随访1年。
  • ADM组68侧乳房,无ADM组61侧乳房接受了组织扩张器更换为假体。

主要发现

  • 假体波纹发生率ADM组24.6% vs 无ADM组12.1%,p=0.08。
  • 包膜挛缩发生率ADM组4.5% vs 无ADM组3.3%,p=1.00。
  • 假体取出率ADM组6.6% vs 无ADM组1.7%,p=0.67。
  • BREAST-Q评分两组相似,例外为假体波纹相关的身体健康和满意度在无ADM组改善(p=0.04)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As prepectoral implant placement becomes widely adopted, recent studies investigating the use of acellular dermal matrix (ADM) during tissue expander placement have demonstrated no major benefit with regard to postoperative outcomes. We sought to evaluate second-stage outcomes 1 year after tissue expander exchange to implant with and without ADM. Consecutive patients who underwent prepectoral tissue expander-based breast reconstruction with and without ADM were identified. Patients were followed up for 1 year after tissue expander exchange to implant. Second-stage outcomes of interest including implant rippling, capsular contracture, implant explantation, additional revision surgeries, and patient-reported outcomes were collected and compared. Sixty-eight breasts in the ADM cohort and sixty-one breasts in the no ADM cohort underwent tissue expander exchange to implant. Second-stage outcomes of interest were similar between the ADM and no ADM cohorts with no statistically significant differences identified regarding incidences of implant rippling (24.6% vs. 12.1%, p = 0.08), capsular contracture (4.5% vs. 3.3%, p = 1.00), and explantation (6.6% vs. 1.7%, p = 0.67) between the two cohorts. BREAST-Q scores were similar between the two cohorts with the exception of physical wellbeing and satisfaction in terms of implant rippling, as can be seen, which improved in the no ADM cohort (p = 0.04). Our study reports no major benefit for the inclusion of ADM with respect to implant rippling, capsular contracture, explantation, need for additional revision surgeries, and patient-reported satisfaction in prepectoral second-stage implant-based breast reconstruction.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Marquez JL, French M, Ormiston L, et al. Outcomes after tissue expander exchange to implant in two-stage prepectoral breast reconstruction with and without acellular dermal matrix: A retrospective cohort study. J Plast Reconstr Aesthet Surg. 2023. PMID: 38160591. doi:10.1016/j.bjps.2023.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。